• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Alvotech - Ordinary Shares (NQ:ALVO)

    3.340 +0.040 (+1.21%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 246,985
    Open 3.310
    Bid (Size) 3.300 (200)
    Ask (Size) 3.350 (700)
    Prev. Close 3.300
    Today's Range 3.310 - 3.370
    52wk Range 3.030 - 11.85
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Alvotech Announces a Change in its Executive Team
    From Alvotech
    Via GlobeNewswire
    News headline image
    Alvotech to Report Financial Results for the First Quarter of 2026
    From Alvotech
    Via GlobeNewswire

    Performance

    YTD
    -33.2%
    -33.2%
    1 Month
    -2.6%
    -2.6%
    3 Month
    -38.4%
    -38.4%
    6 Month
    -57.4%
    -57.4%
    1 Year
    -57.4%
    -57.4%

    More News

    Read More
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Alvotech Files Annual Report with the SEC
    From Alvotech
    Via GlobeNewswire
    Alvotech (NASDAQ:ALVO) Reports Q4 Revenue Beat but Significant EPS Miss, Stock Falls on Weak Guidance ↗
    Via Chartmill
    News headline image
    Alvotech Q4 2025 and Full Year 2025 Financial Results
    From Alvotech
    Via GlobeNewswire
    News headline image
    Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
    From Alvotech
    Via GlobeNewswire
    News headline image
    ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    Why Is ALVO Stock Rising Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
    From Alvotech
    Via GlobeNewswire
    News headline image
    Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
    From Alvotech
    Via GlobeNewswire
    News headline image
    Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
    From Alvotech
    Via GlobeNewswire
    News headline image
    The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion
    Via MarketMinute
    Topics Bankruptcy Earnings Economy
    News headline image
    Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Alvotech announces planned CEO succession and leadership transition
    From Alvotech
    Via GlobeNewswire
    News headline image
    ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
    From Kirby McInerney LLP
    Via Business Wire
    News headline image
    ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Alvotech Secures Term Loan Facility of USD 100 Million
    From Alvotech
    Via GlobeNewswire
    News headline image
    Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
    From Alvotech
    Via GlobeNewswire
    News headline image
    Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
    From Teva Pharmaceutical Industries Ltd
    Via GlobeNewswire
    News headline image
    ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Continues Investigations into Beyond Meat and Alvotech on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire

    Frequently Asked Questions

    Is Alvotech - Ordinary Shares publicly traded?
    Yes, Alvotech - Ordinary Shares is publicly traded.
    What exchange does Alvotech - Ordinary Shares trade on?
    Alvotech - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Alvotech - Ordinary Shares?
    The ticker symbol for Alvotech - Ordinary Shares is ALVO on the Nasdaq Stock Market
    What is the current price of Alvotech - Ordinary Shares?
    The current price of Alvotech - Ordinary Shares is 3.340
    When was Alvotech - Ordinary Shares last traded?
    The last trade of Alvotech - Ordinary Shares was at 04/30/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.